Literature DB >> 18453589

Mannan chain length controls lipoglycans signaling via and binding to TLR2.

Jérôme Nigou1, Thierry Vasselon, Aurélie Ray, Patricia Constant, Martine Gilleron, Gurdyal S Besra, Iain Sutcliffe, Gérard Tiraby, Germain Puzo.   

Abstract

TLR2 is a pattern-recognition receptor that is activated by a large variety of conserved microbial components, including lipoproteins, lipoteichoic acids, and peptidoglycan. Lipoglycans are TLR2 agonists found in some genera of the phylogenetic order Actinomycetales, including Mycobacterium. They are built from a mannosyl-phosphatidyl-myo-inositol anchor attached to a (alpha1-->6)-linked d-mannopyranosyl chain whose units can be substituted by d-mannopyranosyl and/or d-arabinofuranosyl units. At this time, little is known about the molecular bases underlying their ability to induce signaling via this receptor. We have recently shown that the anchor must be at least triacylated, including a diacylglyceryl moiety, whereas the contribution of the glycosidic moiety is not yet clearly defined. We show herein that lipoglycan activity is directly determined by mannan chain length. Indeed, activity increases with the number of units constituting the (alpha1-->6)-mannopyranosyl backbone but is also critically dependent on the substitution type of the 2-hydroxyl of these units. We thus provide evidence for the definition of a new pattern that includes the nonlipidic moiety of the molecules, most probably as a result of the (alpha1-->6)-mannopyranosyl backbone being a highly conserved structural feature among lipoglycans. Moreover, we demonstrate that lipoglycans can bind cell surface-expressed TLR2 and that their ability to induce signaling might be, at least in part, dictated by their avidity for the receptor. Finally, our data suggest that lipoglycans and lipoproteins have a common binding site. The present results are thus discussed in the light of the recently published crystal structure of a TLR1-TLR2-lipopeptide complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453589     DOI: 10.4049/jimmunol.180.10.6696

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Authors:  Christina L Lancioni; Qing Li; Jeremy J Thomas; XueDong Ding; Bonnie Thiel; Michael G Drage; Nicole D Pecora; Assem G Ziady; Samuel Shank; Clifford V Harding; W Henry Boom; Roxana E Rojas
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  A network of hydrogen bonds on the surface of TLR2 controls ligand positioning and cell signaling.

Authors:  Andrey V Kajava; Thierry Vasselon
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

3.  Commensal Fungi Recapitulate the Protective Benefits of Intestinal Bacteria.

Authors:  Tony T Jiang; Tzu-Yu Shao; W X Gladys Ang; Jeremy M Kinder; Lucien H Turner; Giang Pham; Jordan Whitt; Theresa Alenghat; Sing Sing Way
Journal:  Cell Host Microbe       Date:  2017-11-22       Impact factor: 21.023

4.  Mycobacterium tuberculosis promotes HIV trans-infection and suppresses major histocompatibility complex class II antigen processing by dendritic cells.

Authors:  Morgan A Reuter; Nicole D Pecora; Clifford V Harding; David H Canaday; David McDonald
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

6.  Secondary Extended Mannan Side Chains and Attachment of the Arabinan in Mycobacterial Lipoarabinomannan.

Authors:  Shiva K Angala; Wei Li; Claudia M Boot; Mary Jackson; Michael R McNeil
Journal:  Commun Chem       Date:  2020-08-07

7.  Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2.

Authors:  Michael G Drage; Han-Chun Tsai; Nicole D Pecora; Tan-Yun Cheng; Ahmad R Arida; Supriya Shukla; Roxana E Rojas; Chetan Seshadri; D Branch Moody; W Henry Boom; James C Sacchettini; Clifford V Harding
Journal:  Nat Struct Mol Biol       Date:  2010-08-08       Impact factor: 15.369

8.  The structure of the first representative of Pfam family PF06475 reveals a new fold with possible involvement in glycolipid metabolism.

Authors:  Constantina Bakolitsa; Abhinav Kumar; Daniel McMullan; S Sri Krishna; Mitchell D Miller; Dennis Carlton; Rafael Najmanovich; Polat Abdubek; Tamara Astakhova; Hsiu Ju Chiu; Thomas Clayton; Marc C Deller; Lian Duan; Ylva Elias; Julie Feuerhelm; Joanna C Grant; Slawomir K Grzechnik; Gye Won Han; Lukasz Jaroszewski; Kevin K Jin; Heath E Klock; Mark W Knuth; Piotr Kozbial; David Marciano; Andrew T Morse; Edward Nigoghossian; Linda Okach; Silvya Oommachen; Jessica Paulsen; Ron Reyes; Christopher L Rife; Christina V Trout; Henry van den Bedem; Dana Weekes; Aprilfawn White; Qingping Xu; Keith O Hodgson; John Wooley; Marc André Elsliger; Ashley M Deacon; Adam Godzik; Scott A Lesley; Ian A Wilson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-27

9.  A tethering mechanism for length control in a processive carbohydrate polymerization.

Authors:  John F May; Rebecca A Splain; Christine Brotschi; Laura L Kiessling
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

10.  A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis.

Authors:  Antoine Tanne; Bo Ma; Frédéric Boudou; Ludovic Tailleux; Hélène Botella; Edgar Badell; Florence Levillain; Maureen E Taylor; Kurt Drickamer; Jérome Nigou; Karen M Dobos; Germain Puzo; Dietmar Vestweber; Martin K Wild; Marie Marcinko; Peter Sobieszczuk; Lauren Stewart; Daniel Lebus; Brigitte Gicquel; Olivier Neyrolles
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.